- Home
- FOUR vs LNTH Comparison
FOUR vs LNTH Comparison
Compare FOUR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOUR | LNTH |
|---|---|---|
| Founded | 1999 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 3.8B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FOUR | LNTH |
|---|---|---|
| Price | $70.15 | $59.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 6 |
| Target Price | ★ $101.29 | $74.17 |
| AVG Volume (30 Days) | ★ 2.5M | 1.2M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.66 | N/A |
| EPS | 2.15 | ★ 2.39 |
| Revenue | ★ $3,878,400,000.00 | $1,525,933,000.00 |
| Revenue This Year | $29.38 | $0.01 |
| Revenue Next Year | $26.46 | $1.24 |
| P/E Ratio | $32.62 | ★ $24.98 |
| Revenue Growth | ★ 23.16 | 1.95 |
| 52 Week Low | $61.23 | $47.25 |
| 52 Week High | $127.50 | $111.29 |
Technical Indicators
Market Signals| Indicator | FOUR | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 47.04 | 64.06 |
| Support Level | $64.78 | $57.44 |
| Resistance Level | $75.35 | $59.30 |
| Average True Range (ATR) | 2.70 | 1.94 |
| MACD | 0.73 | 0.62 |
| Stochastic Oscillator | 50.73 | 96.63 |
Price Performance
Historical ComparisonAbout FOUR Shift4 Payments Inc.
Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.